Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending October 28, 2013. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 232,000 Ordinary Shares of 25 pence each.
- Purchase Date: October 28, 2013.
- Price Range: Highest price paid was 1,630.00 pence per share; lowest price paid was 1,607.50 pence per share.
- Treasury Holdings (Settled): 507,352,912 shares (9.45% of total issued share capital).
- Treasury Holdings (Including Unsettled): 507,894,912 shares (10.44% of total voting rights).
- Shares in Issue (Excluding Treasury): 4,862,709,913 shares.
Material Changes
The filing reports an incremental increase in the Company's treasury share holdings following the purchase of 232,000 shares. No other material changes to financial position or operations are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance disclosure regarding share buybacks under the Financial Conduct Authority's Disclosure and Transparency Rules.
Key Facts for Investor Verification
- Verify the total number of shares held in Treasury (507,352,912 settled) against the Company's latest annual report to confirm the 9.45% ownership stake.
- Confirm the total voting rights denominator (4,862,709,913 shares) for calculating disclosure thresholds under FCA rules.
- Note that the repurchase price range (1,607.50 to 1,630.00 pence) reflects market conditions on October 28, 2013.
- Understand that this filing does not contain operational or financial performance data for the period.